BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6544812)

  • 41. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma.
    Kashyap R; Babbar A; Sahai I; Prakash R; Soni NL; Chauhan UP
    Clin Nucl Med; 1992 Feb; 17(2):119-22. PubMed ID: 1314148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma.
    Hilditch TE; Connell JM; Elliot AT; Murray T; Reed NS
    J Nucl Med; 1986 Jul; 27(7):1150-3. PubMed ID: 3014086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An unusual cause of an isolated, focal splenic defect demonstrated by liver-spleen scintigraphy.
    Waller RM; Fajman WA
    Clin Nucl Med; 1982 Jan; 7(1):5-7. PubMed ID: 7060295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidental skeletal metastases from prostate cancer detected by sulfur colloid liver-spleen imaging.
    Koci TM; Renslo R; Marcus CS
    Clin Nucl Med; 1989 Mar; 14(3):225-6. PubMed ID: 2736850
    [No Abstract]   [Full Text] [Related]  

  • 45. Tc-99m diphosphonate and sulfur colloid uptake by the spleen in sickle disease: interrelationship and clinical correlates: concise communication.
    Silberstein EB; DeLong S; Cline J
    J Nucl Med; 1984 Dec; 25(12):1300-3. PubMed ID: 6502253
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Technetium 99m pentavalent dimercaptosuccinic acid and thallium 201 in detecting recurrent medullary carcinoma of the thyroid.
    Bigsby RJ; Lepp EK; Litwin DE; Wilkinson AA; Matte GG
    Can J Surg; 1992 Aug; 35(4):388-92. PubMed ID: 1323381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Scintigraphy of hepatic hemangiomas: the value of Tc-99m-labeled red blood cells: concise communication.
    Royal HD; Israel O; Parker JA; Kolodny GM
    J Nucl Med; 1981 Aug; 22(8):684-7. PubMed ID: 7264756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review: Medullary carcinoma of the thyroid: radiographic features of a unique tumor.
    McCook TA; Putman CE; Dale JK; Wells SA
    AJR Am J Roentgenol; 1982 Jul; 139(1):149-55. PubMed ID: 7046403
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Diagnostic effectiveness of 99mTc-phytate colloid in the study of the hepatolienal area].
    Zubovskiĭ GA; Devishev MI; Ogneva TV; Zelentsov BA; Zuĭkova VN
    Med Radiol (Mosk); 1982 Jan; 27(1):24-8. PubMed ID: 6977079
    [No Abstract]   [Full Text] [Related]  

  • 50. I-131 total-body scan: localization of disseminated gastric adenocarcinoma. Case report and survey of the literature.
    Wu SY; Kollin J; Coodley E; Lockyer T; Lyons KP; Moran E; Parker LN; Yu AC
    J Nucl Med; 1984 Nov; 25(11):1204-9. PubMed ID: 6092568
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Medullary carcinoma of the thyroid and 99mTc(V)-DMSA scintigraphy. Clinical results with a new radiopharmaceutical].
    Kujat C; Neidl K; Müller-Leisse C
    Rofo; 1990 Nov; 153(5):495-500. PubMed ID: 2173051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
    Eising EG; Farahati J; Bier D; Knust EJ; Reiners C
    Nuklearmedizin; 1995 Feb; 34(1):1-7. PubMed ID: 7724358
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Normal appearance and reproducibility of liver-spleen studies with Tc-99m sulfur colloid and Tc-99m microalbumin colloid.
    Klingensmith WC; Spitzer VM; Fritzberg AR; Kuni CC
    J Nucl Med; 1983 Jan; 24(1):8-13. PubMed ID: 6217301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tc-99m DMSA scintigraphy on patients with medullary thyroid carcinoma.
    Groth P; Unterspann S; Schwähn D; Stoll I; Reincke R
    Radiobiol Radiother (Berl); 1987; 28(5):642-4. PubMed ID: 2831560
    [No Abstract]   [Full Text] [Related]  

  • 55. Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication.
    Van Duzee BF; Schaefer JA; Ball JD; Chilton HM; Cowan RJ; Kuni C; Trow R; Watson NE
    J Nucl Med; 1984 Feb; 25(2):166-9. PubMed ID: 6233404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Scintigraphic elvaluation of liver metastases from thyroid carcinoma.
    Woolfenden JM; Waxman AD; Wolfstein RS; Siemsen JK
    J Nucl Med; 1975 Jul; 16(7):669-71. PubMed ID: 1151489
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liver scintigraphy in colon carcinoma: correlation with modified Duke pathological classification.
    Tanasescu DE; Waxman AD; Drickman MV; Brachman MB; Ramanna L; Berman DS; Waisman J
    Radiology; 1982 Nov; 145(2):453-5. PubMed ID: 7134452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Radionuclide bone scanning in patients with breast carcinoma. Study of lesions by stages, locations and diagnostic assessment].
    Benítez A; Torres M; García A; Rebollo AC; Pacheco C; Vallejo JA; Contreras PI; Infante J; Mateo A
    Rev Esp Med Nucl; 1998; 17(6):435-41. PubMed ID: 9873131
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metastatic liver disease visualized in a bone scan.
    Berná L; Carrió I; Estorch M
    Clin Nucl Med; 1988 Mar; 13(3):218. PubMed ID: 3383531
    [No Abstract]   [Full Text] [Related]  

  • 60. CT demonstration of calcified liver metastases in medullary thyroid carcinoma.
    McDonnell CH; Fishman EK; Zerhouni EA
    J Comput Assist Tomogr; 1986; 10(6):976-8. PubMed ID: 3782568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.